http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0421863-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a9057130bebc2a1a84245318386110d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
filingDate 1990-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be9bdf72320a95f6b07d1020cc59069c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efd75868f9c1dd58cbc6b908e57f2b5a
publicationDate 1991-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0421863-A1
titleOfInvention Therapeutic device for oral administration of a medicament to animals and process for production
abstract The therapeutic elements for the oral administration of a medicament to animals, include an active ingredient contained in an appetizing envelope. The envelope (1) comprises, in intimate mixture, one or more appetizing materials and one or more substances agglomerating the appetizing material and having a high mechanical and thermal resistance and is previously shaped in a hollow form suitable for consumption by the animal. and delimiting an internal volume, said internal volume being filled with an appetizing binder material (3) containing the active principle (2) and conforming to the internal shape of the envelope (1) to ensure continuity between the envelope (1) and said active ingredient (2).
priorityDate 1989-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0208528-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0088051-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8912393-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2032164-A5
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4650673-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0240826-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2576
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413262
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28967
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07562
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID492313
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21825
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13290
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54704426
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84393
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06484
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405446
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226419983
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454164723
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32650
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9654
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID445442
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP32514

Total number of triples: 49.